Nuclear Regulation lncRNA SLERT controls the phase separation of FC / DFCs to facilitate Pol I transcription –… Carmen Lillard Jul 29, 2021 lncRNA SLERT controls the phase separation of FC / DFCs to facilitate Pol I transcription Science Magazine
Nuclear Regulation The m6A reader IMP2 directs autoimmune inflammation via an IL-17 and TNFα-dependent C / EBP… Carmen Lillard Jul 4, 2021 The m6A reader IMP2 directs autoimmune inflammation via an IL-17 and TNFα-dependent C / EBP transcription factor axis Science
Nuclear Regulation Flare Therapeutics is starting Series A funding of $ 82 million to advance its precision oncology… Carmen Lillard May 13, 2021 Flare Therapeutics is starting Series A funding of $ 82 million to advance its precision oncology pipeline based on BioSpace's novel approach to transcription factor drug discovery